Novocebrin

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 592577

CAS#: 36702-84-8

Description: Novocebrin is a central nervous system activator.

Chemical Structure

img
Novocebrin
CAS# 36702-84-8
Instruction

Theoretical Analysis

MedKoo Cat#: 592577
Name: Novocebrin
CAS#: 36702-84-8
Chemical Formula: C20H22ClNOS2
Exact Mass: 391.08
Molecular Weight: 391.970
Elemental Analysis: C, 61.28; H, 5.66; Cl, 9.04; N, 3.57; O, 4.08; S, 16.36

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Novocebrin; D 8955; D-8955; D8955

IUPAC/Chemical Name: alpha-(1-((3,3-Di-3-thienylallyl)amino)ethyl)benzyl alcohol hydrochloride

InChi Key: BRPBPTNOXZNOML-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H21NOS2.ClH/c1-15(20(22)16-5-3-2-4-6-16)21-10-7-19(17-8-11-23-13-17)18-9-12-24-14-18;/h2-9,11-15,20-22H,10H2,1H3;1H

SMILES Code: CC(C(O)C1=CC=CC=C1)NC/C=C(C2=CSC=C2)/C3=CSC=C3.[H]Cl

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 391.97 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Thiemer K, Stroman F, Szelenyi I, von Schlichtegroll A. [Pharmacological effect of tinofedrine on cerebral and peripheral hemodynamics in the dog (author's transl)]. Arzneimittelforschung. 1978;28(8):1343-54. German. PubMed PMID: 582400.

2: Obermeier K, Niebch G, Thiemer K, Vergin H. [Studies on the pharmacokinetics and metabolism of tinofedrine]. Arzneimittelforschung. 1978;28(8):1360-7. German. PubMed PMID: 582402.

3: Obermeier K, Thiemer K, von Schlichtegroll A. [The influence of tinofedrine on cerebral energy metabolism in normotensive, hypotensive and hypoxemic rats after carotis ligation (author's transl)]. Arzneimittelforschung. 1978;28(8):1354-60. German. PubMed PMID: 582401.

4: Engel J, von Schlichtegroll A, Sheldrick WS. Synthesis and absolute configuration of a tinofedrine-oxazolidine derivative. Arzneimittelforschung. 1982;32(5):475-7. PubMed PMID: 7201821.

5: Saus A, Posselt K. [Synthesis of radioactively labelled tinofedrine (author's transl)]. Arzneimittelforschung. 1980;30(6):917-8. German. PubMed PMID: 7191263.

6: Thiele K, Posselt K, Heese J, Engel J. [Spectroscopic characterisation of tinofedrine (author's transl)]. Arzneimittelforschung. 1980;30(7):1057-9. German. PubMed PMID: 7191286.

7: Lehmann R, Denes R, Nienhaus R, Steinbach T, Lusztig G, Sanatger RM. Alteration of chromatin in early experimental arteriosclerosis. Artery. 1980;8(3):288-93. PubMed PMID: 7213038.

8: Thiele K, Posselt K, Offermanns H, Thiemer K. [New cerebrally active basic dithienyl compounds (author's tranls)]. Arzneimittelforschung. 1980;30(5):747-51. German. PubMed PMID: 7190413.

9: Spehr W. [The effect of tinofedrine on the EEG]. Arzneimittelforschung. 1978;28(8):1312-3. German. PubMed PMID: 582394.

10: Kleemann A, Heese J, Engel J. [Synthesis of germinal 3,3-dithienyl compounds (author's transl)]. Arzneimittelforschung. 1981;31(8):1178-83. German. PubMed PMID: 7197525.

11: Stroman F, Thiemer K. [Investigations on the general effects of tinofedrine on heart and blood circulation (author's transl)]. Arzneimittelforschung. 1981;31(11):1892-902. German. PubMed PMID: 7198471.

12: Ott E, Lechner H. [The effect of tiofedrine on brain perfusion in patients with cerebrovascular insufficiency]. Z Gesamte Inn Med. 1981 Feb 15;36(4):124-6. German. PubMed PMID: 7222859.

13: Thjemer K, Obermeier K. [Effect of tinofedrine on oxygen, glucose and lactate metabolism in dogs and rats]. Arzneimittelforschung. 1981;31(4):693-700. German. PubMed PMID: 7195717.

14: Merory J, Du Boulay GH, Marshall J, Morris J, Russell RW, Symon L, Thomas DJ. Effect of tinofedrine (Homburg D8955) on cerebral blood flow in multi-infarct dementia. J Neurol Neurosurg Psychiatry. 1978 Oct;41(10):900-2. PubMed PMID: 731238; PubMed Central PMCID: PMC493190.

15: Thiele K, Posselt K, Offermanns H. [On the synthesis of the cerebrally active compound tinofedrine (author's transl)]. Arzneimittelforschung. 1978;28(11):2047-8. German. PubMed PMID: 582902.

16: Jakovlev V, Thiemer K, Habersang S, Achterrath-Tuckermann U, von Schlichtegroll A, Sofia RD. [General pharmacological studies on tinofedrine (author's transl)]. Arzneimittelforschung. 1978;28(8):1335-43. German. PubMed PMID: 582399.

17: Lechner H, Ott E. [The influence of tinofedrine on fibrinogen and platelet aggregation in patients with recent cerebral infarction (author's transl)]. Klin Wochenschr. 1978 Nov 15;56(22):1137-8. German. PubMed PMID: 713434.